You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HRTX Exercise Disclosure
Duarte Ira · SEC Form 4 · Filed Jun 17, 2026
Exercise
Reported value range
Not reported
Duarte Ira EVP, Chief Financial Officer
HRTX
Heron Therapeutics
HRTX
Transaction date
Jun 16, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 1 day later
HRTX daily price context
Close on/before transaction
$0.38
Jun 16, 2026
First close after public filing
$0.42
Jun 18, 2026
30-day return after filing
+12.74%
Through Jul 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 12,500 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-273552
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.35K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Heron Therapeutics, Inc. /de/ HRTX Current | Exercise | Jun 16, 2026 | Not reported |
| Heron Therapeutics, Inc. /de/ HRTX | Disposition | Jun 16, 2026 | $1.35K |
| Heron Therapeutics, Inc. /de/ HRTX | Exercise | Jun 16, 2026 | $0 |